Source:http://linkedlifedata.com/resource/pubmed/id/20198797
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2010-3-4
|
| pubmed:abstractText |
Ovarian cancer is the most lethal gynecologic neoplasia. The risk of ovarian cancer in Europe is 1 to 80. In 80-90% of cases, the clinical manifestation is in advanced stage. The 5 year survival is for III /IV stage 25%, but for I/II stage is 90%. In the present study we present the molecular and genetic changes of hereditary and sporadic ovarian cancer.
|
| pubmed:language |
bul
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0324-0959
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
48
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
40-3
|
| pubmed:meshHeading | |
| pubmed:year |
2009
|
| pubmed:articleTitle |
[Molecular genetics of ovarian cancer].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|